Search

Start Over Keyword HIV PROTEASE INHIBITORS

  • Development of GLUT4-selective antagonists for multiple myeloma therapy

    Development of GLUT4-selective antagonists for multiple myeloma therapy
    Authors:Changyong Wei, Emory UniversityRicha Bajpai, Emory UniversityHorrick Sharma, Northwestern UniversityMonique Heitmeier, Washington UniversityAtul D. Jain, Northwestern UniversityShannon M Matulis, Emory UniversityAjay Nooka, Emory UniversityRama K. Mishra, Northwestern UniversityPaul W. Hruz, Washington UniversityGary E. Schiltz, Northwestern UniversityMala Shanmugam, Emory University
    Date:2017
    Publisher:Elsevier
    Publication Version:Author Accepted Manuscript (After Peer Review)
    License:Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

  • Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin

    Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
    Authors:Sevim Dalva-Aydemir, Northwestern UniversityRicha Bajpai, Emory UniversityMaylyn Martinez, Northwestern UniversityKehinde U. A. Adekola, Northwestern UniversityIrawati Kandela, Northwestern UniversityChangyong Wei, Emory UniversitySeema Singhal, Northwestern UniversityJennifer E. Koblinski, Northwestern UniversityNoopur S. Raje, Harvard UniversitySteven T. Rosen, City of Hope National Medical CenterMalathy Shanmugam, Emory University
    Date:2015
    Publisher:American Association for Cancer Research
    Publication Version:Author Accepted Manuscript (After Peer Review)